| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 1.48e-07 | 10 | 105 | 4 | GO:0016176 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 3.33e-05 | 35 | 105 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | collagen binding | 6.82e-05 | 81 | 105 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.49e-04 | 51 | 105 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B NID2 MASP1 CALU ACTN4 CLSTN2 ACTN3 SCGN PKD1L3 MYOF ESYT2 NID1 MAN1B1 | 1.52e-04 | 749 | 105 | 13 | GO:0005509 |
| GeneOntologyMolecularFunction | carbohydrate binding | 2.33e-04 | 310 | 105 | 8 | GO:0030246 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 2.71e-04 | 5 | 105 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 7.51e-04 | 34 | 105 | 3 | GO:0017147 | |
| GeneOntologyBiologicalProcess | superoxide metabolic process | 3.92e-06 | 83 | 104 | 6 | GO:0006801 | |
| GeneOntologyBiologicalProcess | superoxide anion generation | 5.23e-06 | 50 | 104 | 5 | GO:0042554 | |
| GeneOntologyBiologicalProcess | peripheral nervous system myelin maintenance | 1.02e-05 | 9 | 104 | 3 | GO:0032287 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid transport | 2.00e-05 | 11 | 104 | 3 | GO:2000192 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transport | 5.89e-05 | 42 | 104 | 4 | GO:0010765 | |
| GeneOntologyBiologicalProcess | response to yeast | 9.62e-05 | 18 | 104 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | myelin maintenance | 9.62e-05 | 18 | 104 | 3 | GO:0043217 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 1.14e-04 | 291 | 104 | 8 | GO:0072593 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 1.33e-04 | 20 | 104 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 1.50e-04 | 4 | 104 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 1.50e-04 | 4 | 104 | 2 | GO:0140213 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 1.79e-04 | 22 | 104 | 3 | GO:0045986 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | UNC13B EEF1AKMT4-ECE2 VPS13C WNT7A VPS25 SCGN NCDN DIPK2A NECAP1 SLC17A5 MYOF MOXD1 SLC12A2 LRP6 TNK2 GPNMB ECE2 | 3.00e-04 | 1307 | 106 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | UNC13B EEF1AKMT4-ECE2 VPS13C WNT7A VPS25 SCGN NCDN DIPK2A NECAP1 SLC17A5 MYOF MOXD1 SLC12A2 LRP6 TNK2 GPNMB ECE2 | 3.52e-04 | 1325 | 106 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | MLL1 complex | 5.65e-04 | 32 | 106 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 6.19e-04 | 33 | 106 | 3 | GO:0044665 | |
| HumanPheno | Prominent coccyx | 1.27e-05 | 6 | 45 | 3 | HP:0040016 | |
| MousePheno | abnormal bile duct morphology | 1.80e-06 | 64 | 81 | 6 | MP:0002928 | |
| Domain | Ldl_recept_b | 8.37e-07 | 14 | 103 | 4 | PF00058 | |
| Domain | LDLRB | 8.37e-07 | 14 | 103 | 4 | PS51120 | |
| Domain | LY | 1.14e-06 | 15 | 103 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.14e-06 | 15 | 103 | 4 | IPR000033 | |
| Domain | SH3 | 2.61e-05 | 216 | 103 | 8 | SM00326 | |
| Domain | SH3 | 2.61e-05 | 216 | 103 | 8 | PS50002 | |
| Domain | SH3_domain | 2.97e-05 | 220 | 103 | 8 | IPR001452 | |
| Domain | TFIID_sub1_DUF3591 | 3.01e-05 | 2 | 103 | 2 | IPR022591 | |
| Domain | TBP-binding | 3.01e-05 | 2 | 103 | 2 | PF09247 | |
| Domain | DUF3591 | 3.01e-05 | 2 | 103 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 3.01e-05 | 2 | 103 | 2 | IPR009067 | |
| Domain | - | 3.01e-05 | 2 | 103 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 3.01e-05 | 2 | 103 | 2 | IPR011177 | |
| Domain | - | 6.19e-05 | 39 | 103 | 4 | 2.120.10.30 | |
| Domain | G2F | 9.00e-05 | 3 | 103 | 2 | SM00682 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.19e-04 | 46 | 103 | 4 | IPR011042 | |
| Domain | G2F | 1.79e-04 | 4 | 103 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 1.79e-04 | 4 | 103 | 2 | PS50993 | |
| Domain | GFP | 1.79e-04 | 4 | 103 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 1.79e-04 | 4 | 103 | 2 | IPR006605 | |
| Domain | SH3_1 | 2.96e-04 | 164 | 103 | 6 | PF00018 | |
| Domain | NIDO_dom | 2.98e-04 | 5 | 103 | 2 | IPR003886 | |
| Domain | NIDO | 2.98e-04 | 5 | 103 | 2 | SM00539 | |
| Domain | NIDO | 2.98e-04 | 5 | 103 | 2 | PF06119 | |
| Domain | NIDO | 2.98e-04 | 5 | 103 | 2 | PS51220 | |
| Domain | EFhand_Ca_insen | 4.45e-04 | 6 | 103 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 4.45e-04 | 6 | 103 | 2 | IPR014837 | |
| Domain | RICIN | 4.83e-04 | 28 | 103 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 4.83e-04 | 28 | 103 | 3 | PS50231 | |
| Domain | Ricin_B_lectin | 5.93e-04 | 30 | 103 | 3 | IPR000772 | |
| Domain | Prot_inhib_I29 | 6.21e-04 | 7 | 103 | 2 | IPR013201 | |
| Domain | PKD | 6.21e-04 | 7 | 103 | 2 | PF00801 | |
| Domain | Inhibitor_I29 | 6.21e-04 | 7 | 103 | 2 | PF08246 | |
| Domain | Inhibitor_I29 | 6.21e-04 | 7 | 103 | 2 | SM00848 | |
| Domain | SH3_9 | 9.10e-04 | 78 | 103 | 4 | PF14604 | |
| Domain | Pkinase_C | 1.10e-03 | 37 | 103 | 3 | IPR017892 | |
| Domain | Lectin_C | 1.20e-03 | 84 | 103 | 4 | PF00059 | |
| Domain | SH3_2 | 1.31e-03 | 86 | 103 | 4 | PF07653 | |
| Domain | C-type_lectin-like | 1.31e-03 | 86 | 103 | 4 | IPR001304 | |
| Domain | SH3_2 | 1.31e-03 | 86 | 103 | 4 | IPR011511 | |
| Domain | Pept_asp_AS | 1.32e-03 | 10 | 103 | 2 | IPR025661 | |
| Domain | Pkinase_C | 1.60e-03 | 42 | 103 | 3 | PF00433 | |
| Domain | Pept_his_AS | 1.60e-03 | 11 | 103 | 2 | IPR025660 | |
| Domain | GFP-like | 1.60e-03 | 11 | 103 | 2 | IPR023413 | |
| Domain | - | 1.60e-03 | 11 | 103 | 2 | 2.40.155.10 | |
| Domain | PKD | 1.60e-03 | 11 | 103 | 2 | PS50093 | |
| Domain | PKD_dom | 1.60e-03 | 11 | 103 | 2 | IPR000601 | |
| Domain | - | 1.60e-03 | 11 | 103 | 2 | 2.60.40.670 | |
| Domain | EGF_dom | 1.92e-03 | 12 | 103 | 2 | IPR024731 | |
| Domain | EGF_3 | 1.92e-03 | 12 | 103 | 2 | PF12947 | |
| Domain | - | 2.04e-03 | 97 | 103 | 4 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 2.20e-03 | 99 | 103 | 4 | IPR016186 | |
| Domain | Kelch_2 | 2.26e-03 | 13 | 103 | 2 | IPR011498 | |
| Domain | Kelch_2 | 2.26e-03 | 13 | 103 | 2 | PF07646 | |
| Domain | Pept_C1 | 2.26e-03 | 13 | 103 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 2.26e-03 | 13 | 103 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 2.26e-03 | 13 | 103 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 2.26e-03 | 13 | 103 | 2 | IPR013128 | |
| Domain | - | 2.35e-03 | 48 | 103 | 3 | 2.120.10.80 | |
| Domain | EGF-like_dom | 2.57e-03 | 249 | 103 | 6 | IPR000742 | |
| Domain | - | 2.62e-03 | 14 | 103 | 2 | 2.60.40.1180 | |
| Domain | CTDL_fold | 2.91e-03 | 107 | 103 | 4 | IPR016187 | |
| Domain | BAR | 3.02e-03 | 15 | 103 | 2 | SM00721 | |
| Domain | Glyco_hydro_b | 3.02e-03 | 15 | 103 | 2 | IPR013780 | |
| Domain | BAR_dom | 3.44e-03 | 16 | 103 | 2 | IPR004148 | |
| Domain | Kelch-typ_b-propeller | 3.47e-03 | 55 | 103 | 3 | IPR015915 | |
| Domain | AGC-kinase_C | 3.65e-03 | 56 | 103 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.65e-03 | 56 | 103 | 3 | PS51285 | |
| Domain | S_TK_X | 3.65e-03 | 56 | 103 | 3 | SM00133 | |
| Domain | - | 3.88e-03 | 17 | 103 | 2 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 3.88e-03 | 17 | 103 | 2 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 3.88e-03 | 17 | 103 | 2 | PS00484 | |
| Domain | TY | 3.88e-03 | 17 | 103 | 2 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 3.88e-03 | 17 | 103 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 3.88e-03 | 17 | 103 | 2 | PF00086 | |
| Domain | BAR | 4.84e-03 | 19 | 103 | 2 | PS51021 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 1.62e-06 | 5 | 78 | 3 | M48999 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 3.22e-06 | 6 | 78 | 3 | M47523 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 5.61e-06 | 7 | 78 | 3 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 5.61e-06 | 7 | 78 | 3 | M47790 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 8.95e-06 | 8 | 78 | 3 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 8.95e-06 | 8 | 78 | 3 | M47715 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 1.34e-05 | 9 | 78 | 3 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 1.34e-05 | 9 | 78 | 3 | M47972 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 1.85e-05 | 29 | 78 | 4 | M39762 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.90e-05 | 10 | 78 | 3 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 1.90e-05 | 10 | 78 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 1.90e-05 | 10 | 78 | 3 | M47615 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 1.90e-05 | 10 | 78 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 1.90e-05 | 10 | 78 | 3 | MM14778 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 2.60e-05 | 11 | 78 | 3 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47501 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.46e-05 | 12 | 78 | 3 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 3.46e-05 | 12 | 78 | 3 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 3.46e-05 | 12 | 78 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 3.46e-05 | 12 | 78 | 3 | M47559 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 3.46e-05 | 12 | 78 | 3 | M45022 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 3.46e-05 | 12 | 78 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 3.46e-05 | 12 | 78 | 3 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 3.46e-05 | 12 | 78 | 3 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 3.46e-05 | 12 | 78 | 3 | MM14550 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 4.48e-05 | 13 | 78 | 3 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 4.48e-05 | 13 | 78 | 3 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 4.48e-05 | 13 | 78 | 3 | M549 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 5.68e-05 | 14 | 78 | 3 | M47390 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 5.68e-05 | 14 | 78 | 3 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 5.68e-05 | 14 | 78 | 3 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 5.68e-05 | 14 | 78 | 3 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 5.68e-05 | 14 | 78 | 3 | M47536 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 5.68e-05 | 14 | 78 | 3 | M3862 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 7.07e-05 | 15 | 78 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 7.07e-05 | 15 | 78 | 3 | M47663 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 7.07e-05 | 15 | 78 | 3 | M26902 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 7.07e-05 | 15 | 78 | 3 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 7.07e-05 | 15 | 78 | 3 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 7.07e-05 | 15 | 78 | 3 | M47971 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 1.05e-04 | 17 | 78 | 3 | M48086 | |
| Pathway | SA_PTEN_PATHWAY | 1.05e-04 | 17 | 78 | 3 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 1.05e-04 | 17 | 78 | 3 | M18895 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 1.48e-04 | 19 | 78 | 3 | M39370 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 1.48e-04 | 19 | 78 | 3 | M47525 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 2.02e-04 | 21 | 78 | 3 | M14966 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.02e-04 | 21 | 78 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.02e-04 | 21 | 78 | 3 | MM14996 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 2.22e-04 | 54 | 78 | 4 | M42568 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 2.30e-04 | 157 | 78 | 6 | MM15226 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.33e-04 | 22 | 78 | 3 | M13897 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.33e-04 | 22 | 78 | 3 | MM15656 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 2.33e-04 | 22 | 78 | 3 | M47919 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 2.55e-04 | 160 | 78 | 6 | M27498 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.61e-04 | 103 | 78 | 5 | MM14752 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 2.66e-04 | 23 | 78 | 3 | MM15952 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 2.66e-04 | 23 | 78 | 3 | M46455 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.66e-04 | 23 | 78 | 3 | MM14993 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 3.03e-04 | 24 | 78 | 3 | M27952 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 3.03e-04 | 24 | 78 | 3 | M47460 | |
| Pathway | WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN | 3.43e-04 | 25 | 78 | 3 | M39533 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 3.43e-04 | 25 | 78 | 3 | M39794 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 3.43e-04 | 25 | 78 | 3 | M39384 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 3.43e-04 | 25 | 78 | 3 | M14301 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 3.87e-04 | 26 | 78 | 3 | MM15017 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 3.87e-04 | 26 | 78 | 3 | M27558 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 3.87e-04 | 26 | 78 | 3 | MM15501 | |
| Pathway | WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION | 3.87e-04 | 26 | 78 | 3 | M48092 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 3.87e-04 | 26 | 78 | 3 | M47456 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 4.33e-04 | 27 | 78 | 3 | M27422 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 4.33e-04 | 27 | 78 | 3 | M1718 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 4.53e-04 | 116 | 78 | 5 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 4.71e-04 | 117 | 78 | 5 | M39530 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 5.37e-04 | 29 | 78 | 3 | M27756 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 5.37e-04 | 29 | 78 | 3 | MM15340 | |
| Pathway | REACTOME_FLT3_SIGNALING | 5.37e-04 | 29 | 78 | 3 | MM15652 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 5.40e-04 | 68 | 78 | 4 | M48322 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 5.94e-04 | 30 | 78 | 3 | M17814 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 5.94e-04 | 30 | 78 | 3 | M27637 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 17912369 | ||
| Pubmed | Differential activation of AKT isoforms by growth factors in human myotubes. | 2.83e-08 | 3 | 107 | 3 | 37879895 | |
| Pubmed | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 2.83e-08 | 3 | 107 | 3 | 38528080 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 15987444 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 19825827 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 16540465 | ||
| Pubmed | Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. | 2.83e-08 | 3 | 107 | 3 | 20102399 | |
| Pubmed | Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. | 2.83e-08 | 3 | 107 | 3 | 18561256 | |
| Pubmed | Differential effects of Akt isoforms on somatic cell reprogramming. | 2.83e-08 | 3 | 107 | 3 | 25037569 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 38396845 | ||
| Pubmed | AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. | 2.83e-08 | 3 | 107 | 3 | 29173281 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 21590431 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 29235817 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 34296180 | ||
| Pubmed | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt. | 2.83e-08 | 3 | 107 | 3 | 17982014 | |
| Pubmed | Opposing functions of Akt isoforms in lung tumor initiation and progression. | 2.83e-08 | 3 | 107 | 3 | 24722238 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 24039187 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 16923958 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 17202487 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 26953242 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 23929892 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 19805051 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 25233414 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 21555366 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 32796067 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 25811375 | ||
| Pubmed | Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. | 2.83e-08 | 3 | 107 | 3 | 20724596 | |
| Pubmed | Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS. | 2.83e-08 | 3 | 107 | 3 | 27098694 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 28931550 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 10579998 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 20398329 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 33325370 | ||
| Pubmed | The Akt isoforms are present at distinct subcellular locations. | 2.83e-08 | 3 | 107 | 3 | 20018949 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 24247267 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 17895832 | ||
| Pubmed | Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. | 2.83e-08 | 3 | 107 | 3 | 10491192 | |
| Pubmed | INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor. | 2.83e-08 | 3 | 107 | 3 | 25883023 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 17210696 | ||
| Pubmed | Role for Akt3/protein kinase Bgamma in attainment of normal brain size. | 2.83e-08 | 3 | 107 | 3 | 15713641 | |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 4.00e-08 | 31 | 107 | 5 | 25838543 | |
| Pubmed | Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos. | 1.13e-07 | 4 | 107 | 3 | 31552693 | |
| Pubmed | Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. | 1.13e-07 | 4 | 107 | 3 | 19933838 | |
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 33139577 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 21242979 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 19435822 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 21507933 | ||
| Pubmed | Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain. | 1.13e-07 | 4 | 107 | 3 | 26227811 | |
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 17942896 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 30567482 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 21763505 | ||
| Pubmed | The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. | 2.82e-07 | 5 | 107 | 3 | 20059950 | |
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 9512493 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 27938661 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 26855332 | ||
| Pubmed | Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. | 2.82e-07 | 5 | 107 | 3 | 17442925 | |
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 22814751 | ||
| Pubmed | Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. | 2.82e-07 | 5 | 107 | 3 | 19289493 | |
| Pubmed | Platelet-derived growth factor protects neurons against gp120-mediated toxicity. | 2.82e-07 | 5 | 107 | 3 | 18300076 | |
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 25246356 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 16931806 | ||
| Pubmed | Brown fat organogenesis and maintenance requires AKT1 and AKT2. | 2.82e-07 | 5 | 107 | 3 | 30833219 | |
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 36640312 | ||
| Pubmed | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. | 2.82e-07 | 5 | 107 | 3 | 26996309 | |
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 4.76e-07 | 50 | 107 | 5 | 19807924 | |
| Pubmed | Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. | 5.62e-07 | 6 | 107 | 3 | 24642468 | |
| Pubmed | mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. | 5.62e-07 | 6 | 107 | 3 | 31996678 | |
| Pubmed | KCTD20, a relative of BTBD10, is a positive regulator of Akt. | 5.62e-07 | 6 | 107 | 3 | 24156551 | |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 14749824 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 23746211 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 12176997 | ||
| Pubmed | Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. | 5.62e-07 | 6 | 107 | 3 | 29038421 | |
| Pubmed | Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. | 5.62e-07 | 6 | 107 | 3 | 10869418 | |
| Pubmed | Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1. | 5.62e-07 | 6 | 107 | 3 | 34385359 | |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 15616007 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 23673657 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 22107784 | ||
| Pubmed | Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. | 5.62e-07 | 6 | 107 | 3 | 11707444 | |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 21606541 | ||
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 5.62e-07 | 6 | 107 | 3 | 12783884 | |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 18160256 | ||
| Pubmed | AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. | 5.62e-07 | 6 | 107 | 3 | 17439945 | |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 20186503 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 23968884 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 19261608 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 23604117 | ||
| Pubmed | Killing activity of neutrophils is mediated through activation of proteases by K+ flux. | 9.82e-07 | 7 | 107 | 3 | 11907569 | |
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 23811558 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 17634444 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 23603832 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 16287854 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 21697490 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 27573815 | ||
| Pubmed | The E3 ligase TRAF6 regulates Akt ubiquitination and activation. | 9.82e-07 | 7 | 107 | 3 | 19713527 | |
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 21295499 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 16841089 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 18826950 | ||
| Pubmed | Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. | 1.57e-06 | 8 | 107 | 3 | 20816796 | |
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 11208609 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 20040596 | ||
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 24469921 | ||
| Interaction | ERO1A interactions | 5.52e-06 | 132 | 104 | 7 | int:ERO1A | |
| Interaction | KREMEN2 interactions | 1.07e-05 | 27 | 104 | 4 | int:KREMEN2 | |
| Cytoband | 19q13.1-q13.2 | 1.92e-04 | 9 | 107 | 2 | 19q13.1-q13.2 | |
| GeneFamily | Actinins | 9.34e-05 | 4 | 72 | 2 | 1112 | |
| GeneFamily | Classical BAR domain containing | 4.31e-04 | 8 | 72 | 2 | 1292 | |
| GeneFamily | Cathepsins | 1.59e-03 | 15 | 72 | 2 | 470 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_UP | 1.64e-05 | 198 | 106 | 7 | M9245 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN | 1.75e-05 | 200 | 106 | 7 | M9040 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | MASP1 CACNB4 SAMD9 NRCAM AGR2 AGR3 INPP4B CCDC83 SLC12A2 ATRNL1 CRYBG1 GPNMB CTSS | 1.76e-05 | 786 | 106 | 13 | M10961 |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP | 2.31e-05 | 377 | 106 | 9 | M40997 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.35e-09 | 170 | 107 | 8 | 2c5a1469e5743870e96e6c2cc92f0c5096b79f51 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.35e-09 | 170 | 107 | 8 | 9bea81031cdfe45e8cddac3a3afd9ca6c331c45a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.85e-08 | 199 | 107 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | SMG-Goblet|World / shred by cell class for bronchial biopsy | 3.52e-07 | 187 | 107 | 7 | 5178118bdec91495253c88f58fd908cf831de7ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-07 | 191 | 107 | 7 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.06e-07 | 191 | 107 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-07 | 191 | 107 | 7 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.35e-07 | 193 | 107 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.50e-07 | 194 | 107 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 4.66e-07 | 195 | 107 | 7 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-07 | 197 | 107 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-07 | 197 | 107 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.35e-07 | 199 | 107 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-07 | 200 | 107 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 200 | 107 | 7 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 5.53e-07 | 200 | 107 | 7 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 5.53e-07 | 200 | 107 | 7 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 5.53e-07 | 200 | 107 | 7 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 5.53e-07 | 200 | 107 | 7 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.53e-07 | 200 | 107 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 4.01e-06 | 174 | 107 | 6 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.53e-06 | 184 | 107 | 6 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.53e-06 | 184 | 107 | 6 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.85e-06 | 191 | 107 | 6 | a8d77095ba20b47fc70ba04f80759fbce873253d | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 7.06e-06 | 192 | 107 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 7.49e-06 | 194 | 107 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.71e-06 | 195 | 107 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.71e-06 | 195 | 107 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.94e-06 | 196 | 107 | 6 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.94e-06 | 196 | 107 | 6 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.94e-06 | 196 | 107 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.94e-06 | 196 | 107 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.94e-06 | 196 | 107 | 6 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.94e-06 | 196 | 107 | 6 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 8.17e-06 | 197 | 107 | 6 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.17e-06 | 197 | 107 | 6 | 72775eb6c24cfb956436642ac9cd6e4d5c01ea5f | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.17e-06 | 197 | 107 | 6 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.17e-06 | 197 | 107 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-06 | 198 | 107 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 8.66e-06 | 199 | 107 | 6 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.91e-06 | 200 | 107 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.91e-06 | 200 | 107 | 6 | af743dfef7e7cfaef1c494999757123f93a213e3 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 1.05e-05 | 206 | 107 | 6 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.52e-05 | 62 | 107 | 4 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.52e-05 | 62 | 107 | 4 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-05 | 144 | 107 | 5 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 3.76e-05 | 156 | 107 | 5 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.87e-05 | 157 | 107 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.11e-05 | 159 | 107 | 5 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 163 | 107 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 163 | 107 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.20e-05 | 167 | 107 | 5 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 167 | 107 | 5 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 167 | 107 | 5 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-05 | 168 | 107 | 5 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-05 | 169 | 107 | 5 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-05 | 169 | 107 | 5 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 5.81e-05 | 171 | 107 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 172 | 107 | 5 | 5401ac7739f95fb8681cfb4747ab6e447a3c2ae8 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.98e-05 | 172 | 107 | 5 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 172 | 107 | 5 | b3da7f488d191214d7bb74fbac189fe8c29ee6cd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 172 | 107 | 5 | 74dd4a7acb2cf857fed20219e4d7dc1adfbaa398 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 173 | 107 | 5 | 3aa1d28d4814798a772808ed29e1dbbdf92abd03 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 173 | 107 | 5 | e8afef5ae68983eb8d6515b43952636a47e9d3d4 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-05 | 174 | 107 | 5 | b1b54e4e23df8cfc04bf298d5c53de203a38b267 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-05 | 176 | 107 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-05 | 176 | 107 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.84e-05 | 177 | 107 | 5 | 2af09028014f4ec3b7d2a4c286f1ae5e84a9f590 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.84e-05 | 177 | 107 | 5 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.03e-05 | 178 | 107 | 5 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 7.22e-05 | 179 | 107 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.41e-05 | 180 | 107 | 5 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-05 | 180 | 107 | 5 | 8af51245ac1269f318268f574cfaddb0b8c80a53 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.61e-05 | 181 | 107 | 5 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.61e-05 | 181 | 107 | 5 | bab282cb0d9fc049f6fb094cf8b1fba104f4ea17 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 181 | 107 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.61e-05 | 181 | 107 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 181 | 107 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.81e-05 | 182 | 107 | 5 | 6d7ba2e1f33aaa499a898ed9587197c0ee625e9a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 182 | 107 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.81e-05 | 182 | 107 | 5 | 94e70746e35a3062015d4b83ee545f4f84f47420 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 182 | 107 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal1-Fos_(Entorhinal_cortex_(IEG))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.82e-05 | 94 | 107 | 4 | a4d0eefede392b55d17ae9995237a2278a570e42 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal1-Fos_(Entorhinal_cortex_(IEG))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.82e-05 | 94 | 107 | 4 | 517e9762e5362b6ff48f0918468a70b736f4d0de | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 183 | 107 | 5 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 183 | 107 | 5 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.22e-05 | 184 | 107 | 5 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 8.22e-05 | 184 | 107 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-05 | 185 | 107 | 5 | d9039770226338fbc3fce92aa229fad96e16db8c | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-05 | 185 | 107 | 5 | b931ab35da10e6e3877071dce9b13fc0da63dc88 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.65e-05 | 186 | 107 | 5 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.65e-05 | 186 | 107 | 5 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.65e-05 | 186 | 107 | 5 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.65e-05 | 186 | 107 | 5 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.87e-05 | 187 | 107 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.51e-05 | 20 | 103 | 3 | DOID:2526 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.48e-05 | 195 | 103 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | malignant astrocytoma (is_marker_for) | 6.95e-05 | 23 | 103 | 3 | DOID:3069 (is_marker_for) | |
| Disease | nidogen-2 measurement | 7.21e-05 | 4 | 103 | 2 | EFO_0020608 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.20e-04 | 5 | 103 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.20e-04 | 5 | 103 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.76e-04 | 702 | 103 | 10 | C0009402 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 1.79e-04 | 6 | 103 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | epididymis-specific alpha-mannosidase measurement | 2.51e-04 | 7 | 103 | 2 | EFO_0801577 | |
| Disease | Nemaline myopathy | 3.33e-04 | 8 | 103 | 2 | cv:C0206157 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.00e-04 | 41 | 103 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.00e-04 | 41 | 103 | 3 | C0858252 | |
| Disease | Epilepsy | 5.88e-04 | 109 | 103 | 4 | C0014544 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 6.50e-04 | 11 | 103 | 2 | EFO_0801461 | |
| Disease | age at menopause | 6.81e-04 | 302 | 103 | 6 | EFO_0004704 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 7.78e-04 | 12 | 103 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | osteoarthritis | 1.11e-03 | 222 | 103 | 5 | MONDO_0005178 | |
| Disease | age at menarche | 1.15e-03 | 594 | 103 | 8 | EFO_0004703 | |
| Disease | relapsing-remitting multiple sclerosis (is_marker_for) | 1.23e-03 | 15 | 103 | 2 | DOID:2378 (is_marker_for) | |
| Disease | unipolar depression, autism spectrum disorder | 1.23e-03 | 15 | 103 | 2 | EFO_0003756, EFO_0003761 | |
| Disease | Malignant neoplasm of liver | 1.57e-03 | 142 | 103 | 4 | C0345904 | |
| Disease | Liver neoplasms | 1.57e-03 | 142 | 103 | 4 | C0023903 | |
| Disease | hearing loss | 1.68e-03 | 67 | 103 | 3 | EFO_0004238 | |
| Disease | Pancreatic carcinoma | 1.99e-03 | 19 | 103 | 2 | C0235974 | |
| Disease | brain age measurement | 2.20e-03 | 20 | 103 | 2 | EFO_0010602 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.27e-03 | 157 | 103 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | lung disease (is_implicated_in) | 2.66e-03 | 22 | 103 | 2 | DOID:850 (is_implicated_in) | |
| Disease | Breast Carcinoma | 2.83e-03 | 538 | 103 | 7 | C0678222 | |
| Disease | Epilepsy, Cryptogenic | 3.00e-03 | 82 | 103 | 3 | C0086237 | |
| Disease | longitudinal BMI measurement | 3.00e-03 | 82 | 103 | 3 | EFO_0005937 | |
| Disease | Awakening Epilepsy | 3.00e-03 | 82 | 103 | 3 | C0751111 | |
| Disease | Aura | 3.00e-03 | 82 | 103 | 3 | C0236018 | |
| Disease | Autism Spectrum Disorders | 3.32e-03 | 85 | 103 | 3 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGWGDQLIWTQTYEE | 46 | O95994 | |
| LEDNDYGRAVDWWGL | 321 | P31749 | |
| VLEDNDYGRAVDWWG | 321 | P31751 | |
| AKGWTQWYDLTEDGT | 901 | A0FGR8 | |
| YRGWVEWIENGIAKG | 91 | Q9UIR0 | |
| GANEEGWRRAVWEKN | 41 | O60911 | |
| RGWGDDITWVQTYEE | 36 | Q8TD06 | |
| NKEWWLAEAQGQKGY | 751 | Q9NXL2 | |
| GWSSDENDWNEKLYP | 46 | Q14956 | |
| GWQHLEQAEKGYEEW | 386 | O43707 | |
| DLKDYWESGEWAIVN | 221 | Q15822 | |
| NTEWWLAEVNGKKGY | 1551 | Q6XZF7 | |
| QKRWIYEDVERQWKG | 101 | O43852 | |
| WQDWTKRIEYQPGSG | 261 | Q9H4D0 | |
| KYNNDWWIGRLVKEG | 131 | O00305 | |
| WQIDFNGGDRWKVES | 101 | Q9NRD1 | |
| YWNGIGVEDWIAAER | 1096 | Q5H9R4 | |
| IEGRAENYWWRGQNT | 416 | Q07912 | |
| NDYGRAVDWWGLGVV | 321 | Q9Y243 | |
| LIDKGSYLEIWENDW | 206 | Q8IWF9 | |
| WGWRTDKAEVVNGYE | 251 | Q8IZ07 | |
| GLVYTEDEWQKEWNE | 246 | Q6GQQ9 | |
| IWSGRDGYRKAWNNQ | 336 | P51610 | |
| NLDKNTVGYLQWRWG | 261 | Q9NVH1 | |
| QEEKYWRGQDVVQEW | 1636 | P78559 | |
| NEWDPIIEWAEKRYG | 156 | Q8N5M1 | |
| QKWGNIEWAHDYELQ | 246 | Q8N5M1 | |
| YEGIWADLQELWFLG | 626 | Q9UBB6 | |
| SKVGEYWWNAILEGE | 266 | Q8IVD9 | |
| QYKVSWRQKDGDDEW | 781 | Q92823 | |
| YDEEEWDRVWANVGK | 516 | O15327 | |
| YKWVDRNSGLTWSGN | 211 | Q9H9K5 | |
| QKEGSLRDWYDFVWN | 711 | O60318 | |
| AGWDYAQWKQEREQI | 231 | Q6ZUT6 | |
| YDKEGNLRPWWQNES | 661 | P0DPD6 | |
| KGSGYWQWDELARTD | 396 | Q99542 | |
| KLRDGDRFWWENEGV | 671 | P05164 | |
| GNLYWTDWNRDNPKI | 1076 | P14543 | |
| WGTRRLLNWIKEEYG | 1251 | P09848 | |
| TYWIDWGENPEIKRA | 91 | A4QPB2 | |
| AVDWLGKNLYWADTG | 711 | O75581 | |
| NDIWRYNEEEKKWEG | 581 | Q2TBA0 | |
| GRRYWEVEVGDKTAW | 651 | O15553 | |
| LDGWWVIRKDDVTGY | 261 | A6NI72 | |
| LDGWWVIRKDDVTGY | 236 | A8MVU1 | |
| TGDRKYQDWGWEILQ | 611 | Q9UKM7 | |
| EVGKTYWNRIFIQGW | 451 | Q5VTY9 | |
| GNLYWTDWNREAPKI | 1241 | Q14112 | |
| LWQVGHLGEKYDEWV | 131 | Q7L5A8 | |
| YSWNWNAIDEGPKRD | 146 | Q9BTY2 | |
| LENWIGDYFEKALQW | 2141 | Q8NCM8 | |
| REYDKEGNLRPWWQN | 731 | P0DPD8 | |
| WGTMWKQLYVRNEGD | 96 | Q8N1I0 | |
| DEGEIQYLIKWKGWS | 301 | O14647 | |
| TGKGWLNHDETWRNY | 396 | Q5T6F0 | |
| DFGLQVSYDWNWRVD | 1786 | Q9Y6R7 | |
| IWGGENFEISYKIWQ | 411 | Q86SF2 | |
| GEELWSYFNAPWEKR | 246 | Q8NDZ4 | |
| WVQDVAYDLWREENG | 181 | Q8J025 | |
| VGLRKINISYWGWED | 811 | Q5VV63 | |
| DNVSKDVPQTRWGYW | 71 | Q9NRY5 | |
| RLWWDGVASDQQKYQ | 81 | Q9Y2E5 | |
| ERGQWYLVGTVSWGD | 656 | P48740 | |
| QKNERVGYLTQAEWW | 486 | Q8IWT3 | |
| GDLNGKEYWLVKNSW | 286 | P25774 | |
| IWWNPEQLKEDSRDY | 811 | Q9H583 | |
| WKAWGGYNGELQSLR | 1296 | Q9Y4K1 | |
| GFWQVWQRFDADEKG | 16 | O76038 | |
| QTGKKYQWDAETQGW | 96 | Q9NRA2 | |
| TDPEKGNWLRYVNWA | 91 | Q13029 | |
| HYLLSQGWWDEEQEK | 366 | P12694 | |
| DGWNKLFDWIQSELY | 136 | P0DJD0 | |
| LWQTEKDDWTVPYGR | 461 | Q96RQ9 | |
| YSGRDWNVKWEENLL | 181 | Q68CR1 | |
| DEEYNVWFLDWGGAL | 606 | Q9UPU3 | |
| LCDQWYLDYGEENWK | 526 | Q9P2J5 | |
| VYKSKIRWWIEENGG | 1126 | Q5K651 | |
| NEDLVYGRWEDNIIW | 491 | Q8IZX4 | |
| VYGRWEDNIIWDAQA | 476 | P21675 | |
| RDYLEEGKKWWIGQN | 71 | Q7Z443 | |
| VWIGLQNDDYETWLN | 1021 | Q13018 | |
| AWGGTSREYKESWGQ | 1476 | Q9H2D6 | |
| SREYKESWGQPEAWE | 1481 | Q9H2D6 | |
| SFKGRWEEWELYQQI | 116 | Q9NY30 | |
| AWRGLEQVEKGYEDW | 381 | Q08043 | |
| WVNGQGDEVKWSFRE | 76 | Q08AH1 | |
| YWLGLNDRAQEGDWR | 311 | Q6ZS10 | |
| EWGKLIYQWVSRSGQ | 106 | Q9BRG1 | |
| WNAAKLFYQWGDAIG | 1271 | Q8N2C7 | |
| LDSEGKYWLGWSQRG | 31 | Q6UVY6 | |
| GLGQLLVWEWQSESY | 351 | Q15269 | |
| EVIDKNSGGWWYVQI | 476 | Q5TCZ1 | |
| EKQESGWWYVRFGEL | 871 | Q5TCZ1 | |
| NLSGWWYIQIEDKEG | 401 | A1X283 | |
| KNTIDVWWLFDDGGL | 1021 | P55011 | |
| EDNVRLWEAGWKQRY | 506 | Q9H0D6 | |
| ELVEAWNQLGEVYWK | 101 | Q8N0Z6 | |
| WNQLGEVYWKKGDVA | 106 | Q8N0Z6 | |
| ENLWGIKSINDYNTW | 2236 | Q709C8 | |
| WTYKWEQINALGADN | 141 | O14795 | |
| EAGRHEELYWGQIWK | 91 | Q14588 | |
| EELYWGQIWKQIASD | 96 | Q14588 | |
| EWGLLDRSQKELYWD | 211 | Q9NWS9 | |
| QGKELWWEGRVFLQD | 61 | P0CI00 | |
| EKQGQYHRDEGWKWG | 136 | O00755 | |
| WKNESGTWIQYGEEK | 611 | Q7Z2W4 | |
| EQEWGNLSEWQKELY | 296 | Q9ULD5 | |
| RGAGGYWRKWQAQDL | 71 | Q9NXA8 | |
| RADCWLIEGDKGYVW | 21 | Q5R3F8 | |
| QDQEGWEYASLIGWK | 1046 | Q9NZM1 | |
| DDLNWLKGIGCYVWD | 4601 | P20929 | |
| DDLNWLKGIGCYVWD | 4846 | P20929 | |
| YRASDWKLDQPDWTG | 31 | Q8NC96 |